Cardinal Health Inc. makes an attractive 11-15% annual free cash flow yield. The company offers high investor safety with a strong balance sheet, leading industry position, and Dividend Aristocrat sta
Cardinal Health (CAH) Specialty Solutions' newly launched Navista TS will help community oncologists to improve patient care and become successful in value-based care while reducing costs.
DUBLIN, Ohio, April 7, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) Specialty Solutions today launched Cardinal Health™ Navista™ Tech Solutions (TS), an advanced suite of technology solutions
You can't stop it, but you can give yourself a chance of keeping up with inflation.
DUBLIN, Ohio, March 30, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) plans to release third-quarter financial results for its fiscal year 2021 on May 6 prior to the opening of trading on the New Y
Cardinal Health may be recovering from its opioid crisis setback in investor demand and valuation. Under normal operating circumstances, Wall Street would be valuing the stock at a price north of $100
In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots
With March almost over, many investors are looking to the second quarter and beyond.
Cardinal Health is one of the three major medical distribution companies in the United States. There are a few issues with Cardinal Health like the fluctuating net income during the last two decades a
Grab these three top stocks - ABT, HOLX and BIO - that continue to show tremendous promise and stand to benefit from the historic stimulus package.
For years, analysts and portfolio managers have anticipated the return of value stocks as the market has moved higher, and for years they have continued to underperform growth stocks.
Cardinal Health (CAH) divests its Cordis business to focus on strategic growth areas.
Cardinal Health Inc. announced Friday an agreement to sell its minimally invasive cardiovascular technology business Cordis for about $1 billion to Hellman & Friedman. Shares of the pharmaceutical dis
DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approxim
Cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and diversified product portfolio.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE